|
Q1 2025
|
89 |
9,036,702 |
49BA.SG, INCY, ACAD, MDGL
|
13F-HR
|
5/15/2025 |
000110465925049518 |
|
Q4 2024
|
95 |
9,361,492 |
INCY, 49BA.SG, ACAD, MDGL
|
13F-HR
|
2/14/2025 |
000110465925014085 |
|
Q3 2024
|
93 |
9,648,757 |
49BA.SG, INCY, ACAD, SMMT
|
13F-HR
|
11/14/2024 |
000110465924118899 |
|
Q2 2024
|
95 |
7,825,077 |
INCY, 49BA.SG, ACAD, MDGL
|
13F-HR
|
8/14/2024 |
000110465924089606 |
|
Q1 2024
|
87 |
7,971,707 |
INCY, 49BA.SG, ACAD, MDGL
|
13F-HR
|
5/15/2024 |
000110465924061996 |
|
Q4 2023
|
84 |
8,788,600 |
INCY, 49BA.SG, ACAD, MDGL
|
13F-HR
|
2/14/2024 |
000110465924024053 |
|
Q3 2023
|
101 |
17,351,037 |
SGEN, 49BA.SG, INCY, ACAD
|
13F-HR
|
11/14/2023 |
000110465923118157 |
|
Q2 2023
|
107 |
17,279,240 |
SGEN, INCY, 49BA.SG, ACAD
|
13F-HR
|
8/14/2023 |
000110465923091343 |
|
Q1 2023
|
105 |
18,379,748 |
SGEN, INCY, 49BA.SG, ACAD
|
13F-HR
|
5/15/2023 |
000110465923060720 |
|
Q4 2022
|
113 |
16,651,382 |
SGEN, INCY, 49BA.SG, BMRN
|
13F-HR
|
2/14/2023 |
000110465923021551 |
|
Q3 2022
|
115 |
15,269,446 |
SGEN, INCY, 49BA.SG, ACAD
|
13F-HR
|
11/14/2022 |
000110465922118527 |
|
Q2 2022
|
117 |
17,626,987 |
SGEN, INCY, 49BA.SG, BMRN
|
13F-HR
|
8/15/2022 |
000110465922091286 |
|
Q1 2022
|
118 |
17,403,462 |
SGEN, INCY, 49BA.SG, ACAD
|
13F-HR
|
5/16/2022 |
000110465922061288 |
|
Q4 2021
|
121 |
20,553,592 |
SGEN, 49BA.SG, INCY, KOD
|
13F-HR
|
2/14/2022 |
000110465922022725 |
|
Q3 2021
|
122 |
22,771,634 |
SGEN, 49BA.SG, INCY, KOD
|
13F-HR
|
11/15/2021 |
000110465921139109 |
|
Q2 2021
|
120 |
22,769,898 |
SGEN, 49BA.SG, INCY, KOD
|
13F-HR
|
8/16/2021 |
000110465921106314 |
|
Q1 2021
|
126 |
23,065,323 |
SGEN, 49BA.SG, INCY, KOD
|
13F-HR
|
5/17/2021 |
000110465921068025 |
|
Q4 2020
|
126 |
26,543,637 |
SGEN, 49BA.SG, INCY, ACAD
|
13F-HR
|
2/16/2021 |
000110465921023833 |
|
Q3 2020
|
120 |
25,025,928 |
SGEN, 49BA.SG, INCY, ACAD
|
13F-HR
|
11/16/2020 |
000110465920125767 |
|
Q2 2020
|
114 |
22,670,991 |
SGEN, INCY, 49BA.SG, ACAD
|
13F-HR
|
8/14/2020 |
000110465920095518 |
|
Q1 2020
|
110 |
16,236,233 |
SGEN, INCY, ACAD, 49BA.SG
|
13F-HR
|
5/15/2020 |
000110465920062575 |
|
Q4 2019
|
99 |
18,809,854 |
SGEN, INCY, 49BA.SG, ACAD
|
13F-HR
|
2/14/2020 |
000110465920021838 |
|
Q3 2019
|
109 |
14,699,689 |
SGEN, INCY, ACAD, 49BA.SG
|
13F-HR
|
11/14/2019 |
000110465919064169 |
|
Q2 2019
|
103 |
14,714,211 |
SGEN, INCY, 49BA.SG, ALXN
|
13F-HR
|
8/14/2019 |
000114420419040033 |
|
Q1 2019
|
96 |
15,621,759 |
SGEN, INCY, 49BA.SG, ALXN
|
13F-HR
|
5/15/2019 |
000114420419026555 |
|
Q4 2018
|
93 |
12,212,527 |
SGEN, INCY, 49BA.SG, ALXN
|
13F-HR
|
2/13/2019 |
000114420419007156 |
|
Q3 2018
|
97 |
15,181,170 |
SGEN, INCY, 49BA.SG, ALXN
|
13F-HR
|
11/14/2018 |
000114420418059891 |
|
Q2 2018
|
119 |
13,308,803 |
SGEN, INCY, 49BA.SG, ALXN
|
13F-HR
|
8/14/2018 |
000114420418044607 |
|
Q1 2018
|
114 |
11,797,988 |
INCY, SGEN, 49BA.SG, ALXN
|
13F-HR
|
5/15/2018 |
000114420418028818 |
|
Q4 2017
|
123 |
11,537,077 |
INCY, SGEN, ALXN, ACAD
|
13F-HR
|
2/14/2018 |
000114420418008839 |
|
Q3 2017
|
121 |
12,330,918 |
INCY, SGEN, ALXN, ACAD
|
13F-HR
|
11/14/2017 |
000114420417058963 |
|
Q2 2017
|
120 |
11,438,426 |
INCY, SGEN, ALXN, ACAD
|
13F-HR
|
8/14/2017 |
000114420417043086 |
|
Q1 2017
|
119 |
12,220,691 |
INCY, SGEN, ACAD, ALXN
|
13F-HR
|
5/15/2017 |
000114420417027430 |
|
Q4 2016
|
133 |
10,200,965 |
SGEN, INCY, Incyte Corporation, ALXN
|
13F-HR
|
2/14/2017 |
000114420417008836 |
|
Q3 2016
|
134 |
11,019,928 |
SGEN, INCY, ABBV, ACAD
|
13F-HR
|
11/14/2016 |
000114420416134352 |
|
Q2 2016
|
135 |
9,537,918 |
INCY, SGEN, ABBV, ACAD
|
13F-HR
|
8/15/2016 |
000114420416119409 |
|
Q1 2016
|
134 |
9,482,104 |
INCY, SGEN, ALXN, ABBV
|
13F-HR
|
5/16/2016 |
000114420416102596 |
|
Q4 2015
|
133 |
12,071,272 |
INCY, SGEN, ALXN, Incyte Corporation
|
13F-HR
|
2/16/2016 |
000114420416082790 |
|
Q3 2015
|
133 |
10,823,762 |
INCY, SGEN, ALXN, ABBV
|
13F-HR
|
11/16/2015 |
000114420415065993 |
|
Q2 2015
|
126 |
11,400,413 |
INCY, SGEN, ALXN, ABBV
|
13F-HR
|
8/14/2015 |
000114420415049845 |
|
Q1 2015
|
130 |
12,022,854 |
PCYC, INCY, GEVA, SGEN
|
13F-HR
|
5/15/2015 |
000114420415031569 |
|
Q4 2014
|
121 |
9,797,208 |
PCYC, INCY, GEVA, SGEN
|
13F-HR
|
2/17/2015 |
000114420415010112 |
|
Q3 2014
|
110 |
7,940,514 |
PCYC, SGEN, Salix 2.75% 5/15/15, GEVA
|
13F-HR
|
11/14/2014 |
000114420414068894 |
|
Q2 2014
|
107 |
8,164,077 |
GEVA, PCYC, SGEN, INCY
|
13F-HR
|
8/14/2014 |
000114420414050184 |
|
Q1 2014
|
108 |
7,867,925 |
SGEN, GEVA, PCYC, INCY
|
13F-HR
|
5/15/2014 |
000114420414031196 |
|
Q4 2013
|
95 |
7,095,729 |
PCYC, SGEN, INCY, GEVA
|
13F-HR
|
2/14/2014 |
000114420414009842 |